Lower dementia risk seen with sodium-glucose cotransporter 2 in seniors 65+ with mood, psychotic disorders

Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is associated with a lower risk for dementia in older adults with mood and psychotic disorders, according to a study

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *